O	0	7	Effects
O	8	10	of
B-intervention	11	17	Health
I-intervention	18	24	Belief
I-intervention	25	30	Model
O	31	36	based
O	37	44	nursing
O	45	58	interventions
O	59	66	offered
O	67	69	at
O	70	74	home
O	75	81	visits
O	82	84	on
B-condition	85	95	lymphedema
O	96	106	prevention
O	107	109	in
O	110	115	women
O	116	120	with
O	121	127	breast
O	128	134	cancer
O	134	135	:
O	136	137	A
O	138	148	randomised
O	149	159	controlled
O	160	165	trial
O	165	166	.

O	167	177	Lymphedema
O	178	180	is
O	181	183	an
O	184	193	important
O	194	203	morbidity
O	204	207	due
O	208	210	to
O	211	214	its
O	215	223	physical
O	224	227	and
O	228	241	psychological
O	242	254	restrictions
O	255	258	and
O	259	268	financial
O	269	275	burden
O	276	278	in
O	279	284	women
O	285	291	having
O	292	298	breast
O	299	305	cancer
O	306	313	surgery
O	313	314	.

O	315	318	The
O	319	324	study
O	325	328	was
O	329	338	performed
O	339	341	to
O	342	349	examine
O	350	357	effects
O	358	360	of
O	361	367	Health
O	368	374	Belief
O	375	380	Model
O	381	382	(
O	382	385	HBM
O	385	386	)
O	387	392	based
O	393	400	nursing
O	401	414	interventions
O	415	420	given
O	421	423	at
O	424	428	home
O	429	435	visits
O	436	438	on
O	439	449	prevention
O	450	452	of
O	453	463	lymphedema
O	464	466	in
B-eligibility	467	472	women
I-eligibility	473	479	having
I-eligibility	480	486	breast
I-eligibility	487	494	surgery
O	494	495	.

O	496	499	The
O	500	505	study
O	506	509	had
O	510	512	an
O	513	525	experimental
O	526	532	design
O	532	533	.

O	534	537	The
O	538	543	study
O	544	552	included
B-total-participants	553	555	72
B-eligibility	556	561	women
I-eligibility	562	571	receiving
I-eligibility	572	584	radiotherapy
I-eligibility	585	590	after
I-eligibility	591	597	breast
I-eligibility	598	605	surgery
O	605	606	,
O	607	609	of
O	610	614	whom
B-intervention-participants	615	617	37
O	618	624	formed
O	625	628	the
O	629	641	intervention
O	642	647	group
O	648	651	and
B-control-participants	652	654	35
O	655	661	formed
O	662	665	the
B-control	666	673	control
I-control	674	679	group
O	679	680	.

O	681	684	The
O	685	691	sample
O	692	695	was
O	696	701	based
O	702	704	on
O	705	717	Consolidated
O	718	726	Standard
O	727	729	of
O	730	739	Reporting
O	740	746	Trials
O	747	748	(
O	748	755	CONSORT
O	755	756	)
O	756	757	.

O	758	762	Data
O	763	767	were
O	768	777	collected
O	778	782	with
O	783	784	a
O	785	793	personal
O	794	805	information
O	806	819	questionnaire
O	819	820	,
O	821	826	Quick
O	826	827	-
O	827	839	Disabilities
O	840	842	of
O	843	846	the
O	847	850	Arm
O	850	851	,
O	852	860	Shoulder
O	861	864	and
O	865	869	Hand
O	870	875	Score
O	876	877	(
O	877	878	Q
O	878	879	-
O	879	883	DASH
O	883	884	)
O	884	885	,
O	886	894	European
O	895	907	Organization
O	908	911	for
O	912	920	Research
O	921	924	and
O	925	934	Treatment
O	935	937	of
O	938	944	Cancer
O	945	952	Quality
O	953	955	of
O	956	960	Life
O	961	964	for
O	965	971	Breast
O	972	978	Cancer
O	979	981	23
O	982	983	(
O	983	988	EORTC
O	989	992	QLQ
O	992	993	-
O	993	997	BR23
O	997	998	)
O	998	999	,
O	1000	1010	Strategies
O	1011	1015	Used
O	1016	1018	by
O	1019	1027	Patients
O	1028	1030	to
O	1031	1038	Promote
O	1039	1045	Health
O	1046	1047	(
O	1047	1052	SUPPH
O	1052	1053	)
O	1053	1054	,
O	1055	1058	Arm
O	1059	1072	Circumference
O	1073	1077	Form
O	1078	1080	at
O	1081	1086	three
O	1087	1091	home
O	1092	1098	visits
O	1099	1101	at
O	1102	1103	3
O	1103	1104	-
O	1104	1109	month
O	1110	1119	intervals
O	1119	1120	.

O	1121	1124	HBM
O	1125	1130	based
O	1131	1138	nursing
O	1139	1152	interventions
O	1153	1162	regularly
O	1163	1170	offered
O	1171	1173	at
O	1174	1178	home
O	1179	1185	visits
O	1186	1190	were
O	1191	1196	found
O	1197	1199	to
B-outcome	1200	1206	create
I-outcome	1207	1215	positive
I-outcome	1216	1223	changes
I-outcome	1224	1226	in
I-outcome	1227	1236	behaviour
I-outcome	1237	1239	of
I-outcome	1240	1250	lymphedema
I-outcome	1251	1261	prevention
O	1262	1265	and
B-outcome	1266	1273	improve
I-outcome	1274	1279	upper
I-outcome	1280	1289	extremity
I-outcome	1290	1299	functions
I-outcome	1299	1300	,
I-outcome	1301	1307	reduce
I-outcome	1308	1312	side
I-outcome	1312	1313	-
I-outcome	1313	1320	effects
I-outcome	1320	1321	,
I-outcome	1322	1329	relieve
I-outcome	1330	1333	arm
I-outcome	1334	1337	and
I-outcome	1338	1344	breast
I-outcome	1345	1353	symptoms
I-outcome	1353	1354	,
I-outcome	1355	1362	enhance
I-outcome	1363	1366	the
I-outcome	1367	1374	quality
I-outcome	1375	1377	of
I-outcome	1378	1382	life
I-outcome	1382	1383	,
I-outcome	1384	1392	increase
I-outcome	1393	1397	self
I-outcome	1397	1398	-
I-outcome	1398	1406	efficacy
I-outcome	1407	1410	and
I-outcome	1411	1416	lower
I-outcome	1417	1420	the
I-outcome	1421	1430	frequency
I-outcome	1431	1433	of
I-outcome	1434	1444	lymphedema
I-outcome	1445	1448	and
I-outcome	1449	1454	costs
O	1454	1455	.

O	1456	1459	The
O	1460	1463	HBM
O	1464	1469	based
O	1470	1477	nursing
O	1478	1491	interventions
O	1492	1501	regularly
O	1502	1509	offered
O	1510	1512	at
O	1513	1517	home
O	1518	1524	visits
O	1525	1528	can
O	1529	1535	create
O	1536	1544	positive
O	1545	1552	changes
O	1553	1555	in
O	1556	1565	behaviour
O	1566	1568	of
O	1569	1579	lymphedema
O	1580	1590	prevention
O	1591	1594	and
O	1595	1602	prevent
O	1603	1613	lymphedema
O	1614	1616	in
O	1617	1622	women
O	1623	1632	receiving
O	1633	1645	radiotherapy
O	1646	1651	after
O	1652	1658	breast
O	1659	1666	surgery
O	1666	1667	.

O	1668	1679	Considering
O	1680	1685	costs
O	1686	1688	of
O	1689	1698	treatment
O	1699	1702	for
O	1703	1713	lymphedema
O	1713	1714	,
O	1715	1720	these
O	1721	1734	interventions
O	1735	1738	can
O	1739	1741	be
O	1742	1752	considered
O	1753	1755	as
O	1756	1760	cost
O	1760	1761	-
O	1761	1770	effective
O	1770	1771	.

O	1772	1779	Nursing
O	1780	1793	interventions
O	1794	1802	directed
O	1803	1810	towards
O	1811	1820	behaviour
O	1821	1823	of
O	1824	1834	preventing
O	1835	1845	lymphedema
O	1846	1849	and
O	1850	1856	follow
O	1856	1857	-
O	1857	1860	ups
O	1861	1863	in
O	1864	1867	the
O	1868	1872	long
O	1872	1873	-
O	1873	1877	term
O	1878	1884	should
O	1885	1887	be
O	1888	1897	supported
O	1898	1900	by
O	1901	1905	home
O	1906	1912	visits
O	1913	1916	and
O	1917	1926	reminders
O	1927	1934	through
O	1935	1940	phone
O	1941	1946	calls
O	1946	1947	.

O	1948	1954	Nurses
O	1955	1961	should
O	1962	1969	perform
O	1970	1973	HBM
O	1974	1979	based
O	1980	1993	interventions
O	1994	2003	regularly
O	2004	2006	at
O	2007	2011	home
O	2012	2018	visits
O	2019	2021	to
O	2022	2029	prevent
O	2030	2040	lymphedema
O	2040	2041	.

O	2042	2047	These
O	2048	2061	interventions
O	2062	2066	were
O	2067	2072	found
O	2073	2075	to
O	2076	2082	reduce
O	2083	2092	financial
O	2093	2099	burden
O	2100	2103	and
O	2104	2108	were
O	2109	2113	cost
O	2113	2114	-
O	2114	2123	effective
O	2123	2124	.
